Open Access Gold as soon as Publ. Version/Full Text is submitted to ZB.
Endocrine and autocrine/paracrine modulators of brown adipose tissue mass and activity as novel therapeutic strategies against obesity and type 2 diabetes.
Horm. Mol. Biol. Clin. Investig. 31:0043 (2017)
The dramatically increasing world-wide prevalence of obesity is recognized as a risk factor for the development of various diseases. The growing research on the role of adipose tissue in controlling energy homeostasis and insulin sensitivity has revealed that the promotion of brown adipose tissue (BAT) activity and the browning of white adipose tissue (WAT) leads to multiple health benefits and prevents obesity and type 2 diabetes (T2D). Inducible thermogenic adipocytes do exist in adult humans and are linked with increased energy combustion and lower body fat mass. Thus brown adipocytes are currently placed at the center of attention for novel therapeutic strategies against metabolic diseases such as obesity and diabetes. Besides the classical, norepinephrine-mediated sympathetic recruitment and activation of thermogenic adipocytes, a number of novel circulating factors have been recently identified to have a positive or negative impact on thermogenic adipocyte formation and activity. In this review their mechanism of action and the plausible therapeutic applications will be summarized and discussed.
Impact Factor
Scopus SNIP
Scopus
Cited By
Cited By
Altmetric
0.000
0.599
7
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Review
Keywords
Bat-derived Factors ; Brown Adipose Tissue ; Endocrine/paracrine/autocrine Factors ; Thermogenesis
Language
english
Publication Year
2017
HGF-reported in Year
2017
ISSN (print) / ISBN
1868-1883
e-ISSN
1868-1891
Quellenangaben
Volume: 31,
Issue: 2,
Article Number: 0043
Publisher
de Gruyter
Publishing Place
Berlin ; Boston, Mass.
Reviewing status
Peer reviewed
Institute(s)
Institute of Diabetes and Cancer (IDC)
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-501900-252
Scopus ID
85030566466
PubMed ID
28850545
Erfassungsdatum
2017-10-24